19th January 2021
Thierry Heles
Allied Minds will henceforth operate without a chief executive after Joseph Pignato announced his decision to resign.
19th January 2021
Thierry Heles
Pitt spinout BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target size.
19th January 2021
Thierry Heles
Existing shareholder Biohaven has agreed to purchase the remaining stake in Kleo Pharmaceuticals, a Yale spinout it first backed in 2016.
18th January 2021
Robert Lavine
Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.
18th January 2021
Thierry Heles
Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.
18th January 2021
Thierry Heles
Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.